Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment

Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment

Although FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) has been proven efficacious in metastatic pancreatic cancer (MPC), physicians hesitate to administer it due to its hematologic toxicities. We investigated the usefulness of primary granulocyte colony-stimulating factor (G-...

Full description

Bibliographic Details
Main Authors: Jae Hyup Jung, Dong Woo Shin, Jaihwan Kim, Jong-Chan Lee, Jin-Hyeok Hwang
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
pancreatic cancer
FOLFIRINOX
G-CSF prophylaxis
Online Access:https://www.mdpi.com/2072-6694/12/11/3137

Similar Items

Similar Items